The dynamics of the incidence of breast cancer in the Moscow region (2011–2018)

Introduction. Breast cancer is a serious medical and social challenge and the statistics around the world look daunting.

Relevance. The incidence of breast cancer is increasing in most countries and this may be due to a number of reasons. First of all, it should be noted the improvement of diagnostic methods, in particular, mass mammographic screening, which allows detecting neoplasms at early stages, before the onset of clinical symptoms. As for mortality rates, in recent years, world statistics show a downward trend in rates.

Goal. To analyze the incidence and mortality rates of breast cancer (BC) in the Moscow Region (MO) for the period from 2011 to 2018. The study of indicators in one of the regions of Russia – MO – is of great importance for determining and predicting the true needs of the population in specialized medical care.

The purpose of the study was to analyze the incidence of breast cancer (breast cancer) in the Moscow Region (MO) for a period of time from 2011 to 2018.

Materials and methods. Some data of the territorial cancer registry of the Ministry of Defense of the Russian Federation on the diagnosis and treatment of patients with breast cancer were used, which will make it possible to determine the needs of this cohort of patients in specialized care.

Results. From 2011 to 2018, 26755 new cases of breast cancer were diagnosed in the Moscow Region. The analysis of the comparative stratification in breast cancer in the medical district made it possible to obtain statistically significant differences indicating an increase in the incidence in the period from 2015–2018 in comparison with the period of 2011–2014. The presented data also indicate a trend towards a decrease in the one-year mortality rate over 8 years: from 6.33% in 2011 to 5.32% in 2018. For the period from 2011 to 2018 (8 years) there is an increase in the number of patients with breast cancer who have been in the medical center under dispensary supervision for 5 years or more.

Conclusions. Analysis of the data obtained on the indicators of morbidity and mortality from malignant neoplasms is of great importance for determining the needs of the population in specialized medical care.

1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492.

2. Choynzonov E.L., Pisareva L.F., Zhuikova L.D., Ananina O.A., Odintsova I.N. Incidence of respiratory system cancer in the Tomsk region (2005–2016). Voprosy onkologii = Problems in Oncology. 2018;64(6):732–738. (In Russ.) doi: 10.37469/0507-3758-2018-64-6-732-738.

3. Pisareva L.F., Odintsova I.N., Ananina O.A., Boyarkina A.P. Cancer incidence among population of Siberia and Far East. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology. 2015;1(1):68–75. (In Russ.) Available at: https://www.siboncoj.ru/jour/article/view/112.

4. Zhuikova L.D., Choinzonov E.L., Ananina O.A., Odintsova I.N. Oncological morbidity in the Siberian and Far Eastern federal districts. Sibirskiy onkolog­ icheskiy zhurnal = Siberian Journal of Oncology. 2019;18(6):5–11. (In Russ.) doi: 10.21294/1814-4861-2019-18-6-5-11.

5. Kogoniya L.M. Survey of cancers morbidity in the northern and north-western administrative districts of Moscow in comparison with all-Moscow and all-Russian values. Sotsialnye aspekty zdorovya naseleniya = Social Aspects of Population Health. 2012;(3):5. (In Russ.) Available at: http://vestnik.mednet.ru/content/view/408/30.

6. Kogonia L.M. Study of changes in mortality from malignant neoplasm in two municipal districts of Moscow (Northern one and North-Eastern one) from 1990 to 2005 (with special focus on situation in 2004). Sotsialnye aspekty zdorovya naseleniya = Social Aspects of Population Health. 2012;(4):5. (In Russ.) Available at: http://vestnik.mednet.ru/content/view/408/lang,ru/.

7. Autier P., Boniol M., Koechlin A., Pizot C., Boniol M. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. BMJ. 2017;359:j5224. doi: 10.1136/bmj.j5224.

8. Clift А.К. Breast screening controversy and the ‘mammography wars’ – two sides to every story. Hong Kong Med J. 2018;24(3):320–321. doi: 10.12809/hkmj187405.

9. Myers E.R., Moorman P., Gierisch J.,Havrilesky L.J., Grimm L.J., Ghate S. et al. Benefits and Harms of Breast Cancer Screening: A Systematic Review. JAMA. 2015;314(15):1615–634. doi: 10.1001/jama.2015.13183.

10. Smith R.A., Andrews K.S., Fedewa S.A., Manassaram-Baptiste D., Saslow D., Wende R.C. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184–210. doi: 10.3322/caac.21557.

11. Morozov S.P., Vetsheva N.N., Ovsyannikov A.G., Ledihova N.V., Panina E.V., Polishchuk N.S., Puchkova O.S. Moscow screening: breast cancer screening with mammography as a method of improving early stage cancer detection. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2019;27(Special Issue):629. (In Russ.) doi: 10.32687/0869-866X-2019-27-si1-623-629.

12. Samorodskaya I.V., Semenov V.Yu. Malignant neoplasms mortality rates in Moscow and Saint Petersburg in 2015 and 2018. Sovremennaya Onkologiya = Journal of Modern Oncology. 2020;22(3):79–84. (In Russ.) doi: 10.26442/18151434.2020.3.200192.

13. Tikhomirova T.M., Gordeeva V.I. On the issue of assessing the risks of cancer morbidity and mortality, taking into account the age and sex structure of the population. Voprosy onkologii = Oncology Issues. 2014;60(5):571–577. (In Russ.) Available at: https://voprosyonkologii.ru/index.php/journal/article/view/179/179.

14. Shirlina N.G., Stasenko V.L., Kolchin A.S. The prevalence of factors of the labor process assotiated with the risc of developing valignant neoplasms. Meditsina truda i promyshlennaya ehkologiya = Russian Journal of Occupational Health and Industrial Ecology. 2019;59(9):814–815. (In Russ.) doi: 10.31089/1026-9428-2019-59-9-814-815.

15. Drapkina O.M., Semenov V.Iu., Samorodskaia I.V. Top ten causes of mortality in Moscow and St-Petersburg in 2015 and 2018. Profilakticheskaia med­ itsina = Russian Journal of Preventive Medicine and Public Health. 2020;23(5):18–24. (In Russ.) doi: 10.17116/profmed20202305118.

16. Khizha V.V., Movchan K.N., Kuzin A.A., Popov S.V., Skryabin O.N., Grinеnko O.A. et al. Statistical data of cancer cases in Saint-Petersburg within 2015–2016. Vestnik Rossiyskoy voenno­meditsinskoy akademii = Bulletin of the Russian Military Medical Academy. 2017;(4):120–122. (In Russ.) Available at: https://elibrary.ru/item.asp?id=32268906.

17. Boitsov S.A., Samorodskaia I.V., Semenov V.Iu. The impact of medical and non-medical factors on population mortality: the economic factors. Problemy sotsialnoi gigieny, zdravookhraneniia i istorii meditsiny = Problems of Social Hygiene, Health Care and the History of Medicine. 2016;24(6):335–340. (In Russ.) Available at: https://elibrary.ru/item.asp?id=27638885.

18. Pedersen J.H., Sørensen J.B., Saghir Z., Flotten O., Brustugun O.T., Ashraf H. et al. Implementation of lung cancer CT screening in the Nordic countries. Acta Oncol. 2017;56(10):1249–1257. doi: 10.1080/0284186X.2017.1329592.